Health Care Center I, Suite 2
1078 West Baltimore Pike
Media, PA 19063
(484) 227-4350
(484) 227-4677 fax
1078 West Baltimore Pike
Media, PA 19063
(484) 227-4350
(484) 227-4677 fax
Most Recent Peer-reviewed Publications
- Higher levels of c-Met expression and phosphorylation identify cell lines with increased sensitivity to AMG-458, a novel selective c-Met inhibitor with radiosensitizing effects.
- Higher Levels of c-Met Expression and Phosphorylation Identify Cell Lines With Increased Sensitivity to AMG-458, a Novel Selective c-Met Inhibitor With Radiosensitizing Effects
- Molecular profiling to optimize treatment in non-small cell lung cancer: A review of potential molecular targets for radiation therapy by the translational research program of the Radiation Therapy Oncology Group
- Simultaneous inhibition of EGFR and PI3K enhances radiosensitivity in human breast cancer
- Heat shock protein 90 inhibition: Rationale and clinical potential
- Occult nodal metastasis in non-small-cell lung cancer: Implications for the radiation oncologist
- Guidelines for the use and interpretation of assays for monitoring autophagy
- The Aurora Kinase A polymorphisms are not associated with recurrencefree survival in prostate cancer patients
- Role of insulin-like growth factor-1 signaling pathway in cisplatin-resistant lung cancer cells
- Therapeutic targets in head and neck squamous cell carcinoma: Identification, evaluation, and clinical translation
- BV6, an IAP antagonist, activates apoptosis and enhances radiosensitization of non-small cell lung carcinoma in vitro
- An approach for online evaluations of dose consequences caused by small rotational setup errors in intracranial stereotactic radiation therapy
- A novel bioluminescence orthotopic mouse model for advanced lung cancer
- The zinc ionophore PCI-5002 radiosensitizes non-small cell lung cancer cells by enhancing autophagic cell death
- PM02734 (elisidepsin) induces caspase-independent cell death associated with features of autophagy, inhibition of the Akt/mTOR signaling pathway, and activation of death-associated protein kinase
- MLN8054, A small molecule inhibitor of Aurora kinase A, sensitizes androgen-resistant prostate cancer to radiation
- Editorial: Cancer stem cells
- No evidence for association of the MDM2-309 T/G promoter polymorphism with prostate cancer outcomes
- The matrix metalloproteinase-7 polymorphism RS10895304 is associated with increased recurrence risk in patients with clinically localized prostate cancer
- Enhanced radiosensitivity of androgen-resistant prostate cancer: AZD1152-mediated aurora kinase B inhibition